ASTRAZENECA PLC (AZN)
Clinical trial NCT05938270 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-08-17 → 2026-06-15 3. primary completion date: 2026-08-17 → 2026-06-15 4. enrollment: 120 → 113 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical